XML 23 R71.htm IDEA: XBRL DOCUMENT v2.4.0.8
Guarantor Financial Information (Condensed Consolidated Statements of Cash Flows) (Details) (USD $)
In Thousands, unless otherwise specified
6 Months Ended
Jun. 28, 2014
Jun. 29, 2013
Cash flows from operating activities:    
Net income/ (loss) $ (16,431) $ 58,823
Earnings in investments in subsidiaries 0 0
Other operating cash flows 57,455 70,357
Net cash provided by operating activities 41,024 129,180
Cash flows from investing activities:    
Capital expenditures (103,531) (54,689)
Acquisitions, net of cash acquired (2,075,651) 0
Investment in unconsolidated subsidiary 0 (44,959)
Note receivable from affiliates 0  
Gross proceeds from disposal of property, plant and equipment and other assets 2,308 1,292
Proceeds from insurance settlements 0 1,981
Payments related to routes and other intangibles (7,312) (649)
Net cash used by investing activities (2,184,186) (97,024)
Cash flows from financing activities:    
Proceeds from long-term debt 1,821,196 0
Payments on long-term debt (287,066) (40)
Borrowings from revolving credit facility 170,143 0
Payments on revolving credit facility (257,254) 0
Net cash overdraft financing 9,529 0
Deferred loan costs (44,865) 0
Issuance of common stock 417 32
Contributions from parent 0 0
Minimum withholding taxes paid on stock awards (5,495) (2,529)
Excess tax benefits from stock-based compensation 1,329 703
Net cash provided/ (used) by financing activities 1,407,934 (1,834)
Effect of exchange rate changes on cash and cash equivalents 8,156 0
Net increase/ (decrease) in cash and cash equivalents (727,072) 30,322
Cash and cash equivalents at beginning of period 870,857 103,249
Cash and cash equivalents at end of period 143,785 133,571
Issuer [Member]
   
Cash flows from operating activities:    
Net income/ (loss) (16,431) 58,823
Earnings in investments in subsidiaries (69,049) (55,485)
Other operating cash flows 81,867 98,273
Net cash provided by operating activities (3,613) 101,611
Cash flows from investing activities:    
Capital expenditures (22,570) (24,344)
Acquisitions, net of cash acquired 0 0
Investment in unconsolidated subsidiary (1,483,007) (44,985)
Note receivable from affiliates 0  
Gross proceeds from disposal of property, plant and equipment and other assets 1,041 744
Proceeds from insurance settlements 0 1,531
Payments related to routes and other intangibles (7,312) (649)
Net cash used by investing activities (1,511,848) (67,703)
Cash flows from financing activities:    
Proceeds from long-term debt 1,100,000  
Payments on long-term debt (252,500) 0
Borrowings from revolving credit facility 122,445  
Payments on revolving credit facility (207,445)  
Net cash overdraft financing 0  
Deferred loan costs (41,390)  
Issuance of common stock 417 32
Contributions from parent 0 0
Minimum withholding taxes paid on stock awards (5,495) (2,529)
Excess tax benefits from stock-based compensation 1,329 703
Net cash provided/ (used) by financing activities 717,361 (1,794)
Effect of exchange rate changes on cash and cash equivalents 0  
Net increase/ (decrease) in cash and cash equivalents (798,100) 32,114
Cash and cash equivalents at beginning of period 857,267 96,945
Cash and cash equivalents at end of period 59,167 129,059
Guarantors [Member]
   
Cash flows from operating activities:    
Net income/ (loss) 85,300 57,362
Earnings in investments in subsidiaries 0 0
Other operating cash flows (36,376) (29,858)
Net cash provided by operating activities 48,924 27,504
Cash flows from investing activities:    
Capital expenditures (38,730) (30,345)
Acquisitions, net of cash acquired (645) 0
Investment in unconsolidated subsidiary (2,217,686) 0
Note receivable from affiliates (204,074)  
Gross proceeds from disposal of property, plant and equipment and other assets 615 548
Proceeds from insurance settlements 0 450
Payments related to routes and other intangibles 0 0
Net cash used by investing activities (2,460,520) (29,347)
Cash flows from financing activities:    
Proceeds from long-term debt 0  
Payments on long-term debt (43) (40)
Borrowings from revolving credit facility 0  
Payments on revolving credit facility 0  
Net cash overdraft financing 0  
Deferred loan costs 0  
Issuance of common stock 0 0
Contributions from parent 2,421,762 0
Minimum withholding taxes paid on stock awards 0 0
Excess tax benefits from stock-based compensation 0 0
Net cash provided/ (used) by financing activities 2,421,719 (40)
Effect of exchange rate changes on cash and cash equivalents 0  
Net increase/ (decrease) in cash and cash equivalents 10,123 (1,883)
Cash and cash equivalents at beginning of period 6,117 5,577
Cash and cash equivalents at end of period 16,240 3,694
Non-guarantors [Member]
   
Cash flows from operating activities:    
Net income/ (loss) (16,251) (1,877)
Earnings in investments in subsidiaries 0 0
Other operating cash flows 11,964 1,942
Net cash provided by operating activities (4,287) 65
Cash flows from investing activities:    
Capital expenditures (42,231) 0
Acquisitions, net of cash acquired (2,075,006) 0
Investment in unconsolidated subsidiary (2,307,591) (44,959)
Note receivable from affiliates 204,074  
Gross proceeds from disposal of property, plant and equipment and other assets 652 0
Proceeds from insurance settlements 0 0
Payments related to routes and other intangibles 0 0
Net cash used by investing activities (4,220,102) (44,959)
Cash flows from financing activities:    
Proceeds from long-term debt 721,196  
Payments on long-term debt (34,523) 0
Borrowings from revolving credit facility 47,698  
Payments on revolving credit facility (49,809)  
Net cash overdraft financing 9,529  
Deferred loan costs (3,475)  
Issuance of common stock 0 0
Contributions from parent 3,586,522 44,985
Minimum withholding taxes paid on stock awards 0 0
Excess tax benefits from stock-based compensation 0 0
Net cash provided/ (used) by financing activities 4,277,138 44,985
Effect of exchange rate changes on cash and cash equivalents 8,156  
Net increase/ (decrease) in cash and cash equivalents 60,905 91
Cash and cash equivalents at beginning of period 7,473 727
Cash and cash equivalents at end of period 68,378 818
Eliminations [Member]
   
Cash flows from operating activities:    
Net income/ (loss) (69,049) (55,485)
Earnings in investments in subsidiaries 69,049 55,485
Other operating cash flows 0 0
Net cash provided by operating activities 0 0
Cash flows from investing activities:    
Capital expenditures 0 0
Acquisitions, net of cash acquired 0 0
Investment in unconsolidated subsidiary 6,008,284 44,985
Note receivable from affiliates 0  
Gross proceeds from disposal of property, plant and equipment and other assets 0 0
Proceeds from insurance settlements 0 0
Payments related to routes and other intangibles 0 0
Net cash used by investing activities 6,008,284 44,985
Cash flows from financing activities:    
Proceeds from long-term debt 0  
Payments on long-term debt 0 0
Borrowings from revolving credit facility 0  
Payments on revolving credit facility 0  
Net cash overdraft financing 0  
Deferred loan costs 0  
Issuance of common stock 0 0
Contributions from parent (6,008,284) (44,985)
Minimum withholding taxes paid on stock awards 0 0
Excess tax benefits from stock-based compensation 0 0
Net cash provided/ (used) by financing activities (6,008,284) (44,985)
Effect of exchange rate changes on cash and cash equivalents 0  
Net increase/ (decrease) in cash and cash equivalents 0 0
Cash and cash equivalents at beginning of period 0 0
Cash and cash equivalents at end of period $ 0 $ 0